Femasys CEO Discusses FemaSeed Pivotal Trial Results and the History of FemBlock Contraception

In an interview with Pharm Exec Associate Editor Don Tracy, Femasys founder and CEO Kathy Lee-Sepsick talks about the results of Femaseed’s pivotal trial, Femblock contraceptives, and how the outcome of the 2024 U.S. presidential election may impact women’s health.